Journal of Endocrinological Investigation

, Volume 38, Issue 12, pp 1291–1299

Relation of resistin to proprotein convertase subtilisin–kexin type 9 levels in coronary artery disease patients with different nutritional status

  • S. Li
  • R. X. Xu
  • Y. Zhang
  • Y. L. Guo
  • C. G. Zhu
  • G. Liu
  • Q. Dong
  • J. J. Li
Original Article

DOI: 10.1007/s40618-015-0310-y

Cite this article as:
Li, S., Xu, R.X., Zhang, Y. et al. J Endocrinol Invest (2015) 38: 1291. doi:10.1007/s40618-015-0310-y

Abstract

Objective

To investigate the association of resistin with proprotein convertase subtilisin–kexin type 9 (PCSK9) levels, another novel regulator of atherosclerosis, in the condition of coronary artery disease (CAD).

Research design and methods

We prospectively enrolled a total of 356 consecutive stable CAD patients who were not treated with lipid-lowering drugs in the present study. The baseline clinical characteristics were collected. Plasma PCSK9 and resistin levels were determined by ELISA. The relationship between plasma PCSK9 and resistin levels was investigated.

Results

Overall, plasma resistin exhibited a positive nonparametric correlation with PCSK9 levels (r = 0.123, p = 0.02). When the patients were classified into groups based on body mass index (BMI), the resistin correlated significantly to the PCSK9 levels in patients with BMI < 25 kg/m2 (r = 0.162, p = 0.026) but not in patients with BMI ≥ 25 kg/m2 (r = 0.087, p = 0.205). Multivariate regression analysis corroborated the relation between the PCSK9 and an elevated resistin level in patients with BMI < 25 kg/m2 independently of traditional parameters including age, sex, BMI, smoking, family history of CAD, systolic blood pressure, glucose, low density lipoprotein cholesterol, white blood cell, neutrophil to lymphocyte ratio, and high-sensitive C-reactive protein.

Conclusions

Plasma resistin was positively related to PCSK9 levels in CAD patients with normal weight, suggesting that the circulating resistin might represent a link with PCSK9 level variations in CAD progression of normal body weight.

Keywords

Proprotein convertase subtilisin/kexin type 9 Resistin Coronary artery disease Obesity 

Abbreviations

CAD

Coronary artery disease

BMI

Body mass index

SBP

Systolic blood pressure

DBP

Diastolic blood pressure

TC

Total cholesterol

LDL-C

Low density lipoprotein cholesterol

HDL-C

High density lipoprotein cholesterol

Apo

Apolipoprotein

WBC

White blood cell

NLR

Neutrophil to lymphocyte ratio

hs-CRP

High-sensitive C-reactive protein

PCSK9

Proprotein convertase subtilisin/kexin type 9

Copyright information

© Italian Society of Endocrinology (SIE) 2015

Authors and Affiliations

  • S. Li
    • 1
  • R. X. Xu
    • 1
  • Y. Zhang
    • 1
  • Y. L. Guo
    • 1
  • C. G. Zhu
    • 1
  • G. Liu
    • 1
  • Q. Dong
    • 1
  • J. J. Li
    • 1
  1. 1.Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical SciencesPeking Union Medical CollegeBeijingChina

Personalised recommendations